secwatch.observer — SEC 8-K summary
======================================

Issuer:     CERO THERAPEUTICS HOLDINGS, INC. (CERO)
CIK:        0001870404
Form:       8-K
Filed at:   2025-02-06T23:59:59+00:00
Accession:  0001213900-25-010731
Event type: other_material
Sentiment:  neutral
Materiality: 0.65
Item codes: 1.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

CERo Therapeutics prices $5M public offering of shares and warrants at $1.96/unit
--------------------------------------------------------------------------------

- Offering of 2,551,020 shares and warrants at combined $1.96 price; gross proceeds ~$5M.
- Warrants exercisable at $1.96 upon shareholder approval, expire 5 years from exercise date.
- Closing expected February 7, 2025; net proceeds for clinical programs and working capital.
- A.G.P./Alliance Global Partners as placement agent; board member and institutional investor participating.
- 90-day lock-up for officers/directors; company restricted from variable rate financings for 180 days.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1870404/000121390025010731/0001213900-25-010731-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1870404/000121390025010731/ea0230158-8k_cerotherap.htm
  HTML page:      https://secwatch.observer/filing/0001213900-25-010731

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer